EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST
Share · US2772531008 (XNYS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST
No Price
28.04.2026 20:00
Current Prices from EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
ETBI
|
USD
|
28.04.2026 20:00
|
0,001 USD
| 0,00 USD |
Company Profile for EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST Share
EastGate Biotech Corp. is a pharmaceutical company. The Company produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. It utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The Company develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). It has its offices in New York, London SF, Cockfosters BP, Los Angeles, Chicago and Las Vegas.
Company Data
Name EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST
Company Eastgate Biotech Corp.
Website
www.EastGateBiotech.com
Primary Exchange
NYSE
NYSE
ISIN US2772531008
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Rosella C. Perri
Country United States of America
Currency USD
Employees 0,0 T
Address 65 Harbour Square Suite 2203Toronto, M5J 2L4Canada, Toronto
IPO Date 2014-03-05
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | ETBI |
More Shares
Investors who hold EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND EATON VANCE TAX-MANAGED BUY-WRITE INCME FUND OF BENEFICIAL INTEREST also have the following shares in their portfolio:

